title: Fetal surgery for myelomeningocele.
abstract: BACKGROUND
  Although in utero treatment of myelomeningocele shows promise in decreasing the morbidity of this disease, the risks to the fetus are significant, and the benefits are unproven.
  
  
  METHODS
  The upcoming trial represents one of the few times that the pediatric neurosurgical community has come together to test a new procedure.
authors.affiliation: Division of Neurosurgery, The Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19087, USA. sutton@email.chop.edu
authors.forename: Leslie N
authors.initials: LN
authors.lastname: Sutton
authors.forename: N Scott
authors.initials: NS
authors.lastname: Adzick
authors.forename: Mark P
authors.initials: MP
authors.lastname: Johnson
mesh_terms: D002557:Cerebrospinal Fluid Shunts / Q000379:methods; D005260:Female; D005315:Fetal Diseases / Q000473:pathology / Q000601:surgery*; D005333:Fetus / Q000601:surgery*; D005865:Gestational Age; D006801:Humans; D007223:Infant; D008279:Magnetic Resonance Imaging; D008591:Meningomyelocele / Q000196:embryology / Q000473:pathology / Q000601:surgery*; D011182:Postoperative Care; D011247:Pregnancy; D013116:Spinal Cord / Q000473:pathology / Q000601:surgery; D016896:Treatment Outcome